Corrigendum to "Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach" [J. Neuroimmunol. 196 (2008) 153-158] (DOI:10.1016/j.jneuroim.2008.02.015);Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach

Journal of Neuroimmunology

Volumn 196, Issue 1-2, 2008, Pages 153-158

  Gini, Beatrice ^a   Laura, Lovato ^a   Riccardo, Cianti ^b   Laura, Cecotti ^c   Marconi, Silvia ^a   Anghileri, Elena ^a   Alessandro, Armini ^b   Giuseppe, Moretto ^d   Luca, Bini ^b   Franco, Ferracci ^c   Bruno, Bonetti ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b SAN MARTINO HOSPITAL   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

AKRIAI; Autoantibodies; DDAHI; Hashimoto's encephalitis; Proteomics

Indexed keywords

ALDEHYDE REDUCTASE; ALDEHYDE REDUCTASE I; ANTISERUM; AUTOANTIGEN; DIMETHYLARGININASE; DIMETHYLARGININASE I; IMMUNOGLOBULIN G; ISOENZYME;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; BRAIN NERVE CELL; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HASHIMOTO ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WHITE MATTER;

EID: 44349175402     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.07.008     Document Type: Erratum

References (21)

1. Brain L., Jellinek E.H., and Ball K. Hashimoto's disease and encephalopathy. Lancet 2 (1966) 512-514
2. Castillo P., Woodruff B., Caselli R., Vernino S., Lucchinetti C., Swanson J., Noseworthy J., Aksamit A., Carter J., Sirven J., Hunder G., Fatourechi V., Mokri B., Drubach D., Pittock S., Lennon V., and Boeve B. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 63 (2006) 197-202
3. Ferracci F., and Carnevale A. The neurological disorder associated with thyroid autoimmunity. J. Neurol. 253 (2006) 975-984
4. Ferracci F., Moretto G., Candeago R.M., Cimini N., Conte F., Gentile M., Papa N., and Carnevale A. Antithyroid antibodies in the CSF - their role in the pathogenesis of Hashimoto's encephalopathy. Neurology 60 (2003) 712-714
5. Gharahdaghi F., Weinberg C.R., Meagher D.A., Imai B.S., and Mische S.M. Mass spectrometry identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20 (1999) 601-605
6. Hellman U., Wernstedt C., Gonez J., and Heldin C.H. Improvement of an "In-Gel" digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing. Anal. Biochem. 224 (1995) 451-455
7. Kothbauer-Margreiter I., Sturzenegger M., Komor J., Baumgartner R., and Hess C.W. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J. Neurol. 243 (1996) 585-593
8. Leiper J.M., Santa Maria J., Chubb A., MacAllister R.J., Charles I.G., Whitley G.S.J., and Vallance P. Identification of two human dimethylarginine dimethylaminohydrolase with distinct tissue distributions and homology with microbial arginine deiminases. Biochem. J. 343 (1999) 209-214
9. MacAllister R.J., Parry H., Kimoto M., Ogawa T., Russel R.J., Hodson H., Whitley G.S.J., and Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. J. Pharmacol. 119 (1996) 1533-1540
10. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., and Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide. J. Neurochem. 68 (1997) 255-264
11. Mark R.J., Pang Z., Geddes J.W., Uchida K., and Mattson M.P. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17 (1997) 1046-1054
12. Migliorini P., Pratesi F., Bongiorni F., Moscato S., Scavuzzo M., and Bombardieri S. The targets of nephritogenic antibodies in systemic autoimmune disorders. Autoimmun. rev. 1 (2002) 168-173
13. Mitchell D., and Petersen D. The oxidation of α, β unsaturated aldehydic products in lipid peroxidation by rat liver aldehyde dehydrogenases. Toxicol. Appl. Pharmacol. 87 (1987) 403-410
14. Ochi H., Horiuchi I., Araki N., Toda T., Araki T., Sato K., Murai H., Osoegawa M., Yamada T., Okamura K., Ogino T., Mizumoto K., Ymashita H., Saya H., and Kira J. Proteomic analysis of human brain identifies α-enolase as a novel autoantigen in Hashimoto's encephalopathy. FEBS 528 (2002) 197-202
15. O'Connor T., Ireland L.S., Harrison D.J., and Hayes J.D. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem. J. 343 (1999) 487-504
16. Oide T., Tokuda T., Yazaki M., Watarai M., Mitsuhashi S., Kaneko K., Hashimoto T., Ohara S., and Ikeda S. Anti-neuronal autoantibody in Hashimoto encephalopathy: neuropathological, immunohistochemical and biochemical analysis of two patients. J. Neurol. Sci. 217 (2004) 7-12
17. Picklo M.J., Olson S.J., Markesbery W.R., and Montine T.J. Expression and activities of aldo-keto oxidoreductases in Alzheimer Disease. J. Neuropathol. Exp. Neurol. 60 (2001) 686-695
18. Rottoli P., Magi B., Cianti R., Bargagli E., Vagaggini C., Nikiforakis N., Pallini V., and Bini L. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 5 (2005) 2612-2618
19. Sinha P., Poland J., Schnolzer M., and Rabilloud T. A new silver staining apparatus and procedure for matrix-assisted laser desorption/ionization-time of flight analysis of proteins after two-dimensional electrophoresis. Proteomics 1 (2001) 835-840
20. Valdo P., Stegagno C., Mazzucco S., Zuliani E., Zanusso G.L., Moretto G., Raine C.S., and Bonetti B. Enhanced expression of NGF receptors in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 61 (2002) 91-98
21. Yoneda M., Fujii A., Ito A., Yokoyama H., Nakagawa H., and Kuriyama M. High prevalence of serum autoantibodies against the amino terminal of α-enolase in Hashimoto's encephalopathy. J. Neuroimmunol. 185 (2007) 195-200